Research & Development: Page 3


  • Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Major clinical trial trends transforming life sciences research

    From AI to diversity and decentralized trials, here’s how clinical trial operations are evolving.

    By June 29, 2023
  • DEI lab
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Pharma is still figuring out how to make DEI work. Here are some of the strategies companies are trying

    Although DEI efforts have ramped up, the industry is still searching for proven ways to get results.

    By Alexandra Pecci • June 28, 2023
  • clinical trial diversity Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Covid-19 illustration with dark blue background
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    A unique study on COVID shows how machine learning can help personalize medicine

    Based on real-world data from patients in China, researchers were able to pinpoint factors that led to recurring infections — and which drug combos helped.

    By Kelly Bilodeau • June 26, 2023
  • microscope
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A

    DIA’s chief exec is on a mission to grow its footprint across healthcare

    Marwan Fathallah came onboard earlier this year to lead the organization into an era of change.

    By June 22, 2023
  • Reenie McCarthy Stealth BioTherapeutics
    Image attribution tooltip
    Permission granted by Reenie McCarthy Stealth BioTherapeutics
    Image attribution tooltip
    Podcast

    Woman of the Week: Stealth BioTherapeutics’ Reenie McCarthy

    How the CEO navigated a regulatory odyssey to bring the company’s lead program for an ultra-rare disease to a fast track approval.

    By June 21, 2023
  • Lab workers against digitized background
    Image attribution tooltip
    metamorworks via Getty Images
    Image attribution tooltip

    AI has secured a footing in drug discovery. Where does it go from here?

    The AI revolution is bringing a new era of drug discovery, and the potential for more uses is greater and faster than ever before.

    By June 20, 2023
  • Abbey Jenkins Gamida Cell
    Image attribution tooltip
    Permission granted by Abbey Jenkins Gamida Cell
    Image attribution tooltip
    Podcast

    Woman of the Week: Gamida Cell’s Abbey Jenkins

    The first-time CEO discusses the lessons she has learned since taking the role last year and how she’s pivoting the company into a commercial entity.

    By June 14, 2023
  • Aerial view of Shanghai at night
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Biotech Spotlight

    Zai Lab looks to expand beyond China and make a global impact in oncology

    Focused on making a “transformational” impact, the company is developing targeted treatments driven by specific cancer mutations.

    By Kelly Bilodeau • June 12, 2023
  • Close up overhead view of full prescription bottles on stainless steel background
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Profile

    Is America ready for a new kind of opioid?

    Tris Pharma’s CEO is “betting the company” on a pain reliever with the power of an opioid and a lower chance of addiction. 

    By Alexandra Pecci • June 12, 2023
  • mushroom brain
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Why cancer could be the ideal realm for psychedelic treatments

    The CEO of Sunstone Therapies said the results of a recent trial testing psilocybin in cancer patients with depression were “remarkable.”

    By June 9, 2023
  • lightbulb pill
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A

    Ranking reveals biopharma’s most innovative companies

    IDEA Pharma’s 12th index finds that Pfizer and AstraZeneca reign supreme again.

    By June 7, 2023
  • Legend Biotech CEO Ying Huang
    Image attribution tooltip
    Permission granted by Legend Biotech
    Image attribution tooltip

    Janssen and Legend’s longtime collaboration lands a CAR-T win at ASCO

    A partnership going on six years between the pharma giant and the Chinese biotech is showing that their CAR-T cell therapy for multiple myeloma is highly effective.

    By June 5, 2023
  • pills rising
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    A key to ‘winning’ in today’s market — and other trends pharma leaders are tracking

    Healthcare pros share the market drivers they believe are having the biggest impact on the industry.

    By June 2, 2023
  • Laurie Stelzer Mirati
    Image attribution tooltip
    Permission granted by Laurie Stelzer Mirati
    Image attribution tooltip
    Podcast

    Woman of the Week: Mirati Therapeutics’ Laurie Stelzer

    With the recent approval of Krazati, the biotech veteran is guiding Mirati into its next phase as a commercial organization.

    By May 31, 2023
  • CVS storefront
    Image attribution tooltip
    Scott Olson via Getty Images
    Image attribution tooltip

    CVS is exiting clinical trials. Does this spell trouble for retail-based research?

    Walgreens leaders are not deterred and hope to fill the holes left behind by the pharmacy giant.

    By Kelly Bilodeau • May 30, 2023
  • Human genome code on a screen
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    The cell ‘atlasing’ approach pushing the limits of drug discovery

    Vizgen’s CEO discusses the potential of spatial genomics in the life sciences and the company’s role in the movement.

    By May 24, 2023
  • Lisa Ricciardi Cognition Therapeutics
    Image attribution tooltip
    Permission granted by Lisa Ricciardi Cognition Therapeutics
    Image attribution tooltip
    Podcast

    Woman of the Week: Cognition Therapeutics’ Lisa Ricciardi

    As CEO of the neurogenerative company, Ricciardi is applying her decades of “human capital” to advance Alzheimer’s and dementia treatments.

    By May 24, 2023
  • space rocket
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Biotechs blast experiments into space

    Conducting life sciences research in space’s microgravity could have far-ranging implications for drug development on Earth.

    By Alexandra Pecci • May 23, 2023
  • DNA genetics
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    The power of genetics — how research into gene sequencing could revolutionize biopharma

    Ancient DNA from a deer tooth. A new way to connect genes with disease. Biological super-computing. These genetic advances could play a part in our biopharma future.

    By May 23, 2023
  • DMD
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Amid surging Duchenne market, Capricor touts potential ‘backbone’ therapy of the space

    The company's CEO on the vital role its late-stage candidate could play in the lives of DMD patients. 

    By Kelly Bilodeau • May 22, 2023
  • team work
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    What pharma can teach biotech about the life cycle management of a drug

    Global product teams are common in pharma but have yet to gain traction in biotech. Here's why this model can work.

    By Dr. Stephen Dale and Kathleen Ford • May 18, 2023
  • Professional headshot of Monica Bertagnolli
    Image attribution tooltip
    (2021). Retrieved from NCI.
    Image attribution tooltip
    Making Moves

    Biden’s pick to lead the NIH faces an uphill battle

    Pending Senate confirmation, NCI head Monica Bertagnolli will take the helm of the collection of research organizations as it faces increasing bipartisan scrutiny. 

    By May 18, 2023
  • Trish Hurter on horseback
    Image attribution tooltip
    Permission granted by Patricia Hurter
    Image attribution tooltip
    Profile

    A day in the life of a pharma exec: Lyndra’s Patricia Hurter

    How the CEO starts each day with a ride on one of her horses, reduces daily meetings and uses her network to get through crises like the SVB Bank collapse.

    By May 17, 2023
  • young cow
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A

    From farm to pharma: How cows could play a role in the next flu breakthrough

    SAb Biotherapeutics is working on a novel product that uses cow antibodies genetically engineered into human antibodies to prevent and treat infectious diseases.

    By Alexandra Pecci • May 16, 2023
  • long covid concept
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Years into the pandemic, only a handful of clinical trials are targeting long COVID — here’s one of them

    Scientists at Stanford are testing Pfizer’s Paxlovid on long COVID symptoms and their efforts could provide clues for other conditions.  

    By Kelly Bilodeau • May 15, 2023